ETHZilla, a Nasdaq-listed Ethereum treasury company, has announced plans to raise $10 billion through a rights offering. The company, formerly known as 180 Life Sciences Corp., disclosed the amendment of its securities sales agreement, allowing it to issue and sell common stock to fund ongoing Ethereum acquisitions. This move is part of ETHZilla's strategy to bolster its Ethereum reserves.
ETHZilla to Raise $10 Billion for Ethereum Purchases via Rights Offering
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.